Parathion
The chemical solution most likely contained parathion (D), an organophosphate pesticide that causes irreversible acetylcholinesterase inhibition and produces the classic cholinergic crisis requiring both atropine and pralidoxime therapy. 1
Why Parathion is the Answer
Parathion is an organophosphate compound that requires dual antidotal therapy with both atropine and pralidoxime, which is exactly what the physician administered in this case. 1 This distinguishes it from the other options:
Clinical Presentation Matches Organophosphate Toxicity
The patient exhibits the complete cholinergic toxidrome:
Muscarinic signs: Salivation, diaphoresis, wheezing (bronchospasm), abdominal pain, bradypnea (8/min), and hypotension (100/55 mmHg) are all classic muscarinic manifestations of organophosphate poisoning. 1
Nicotinic signs: Muscle weakness represents nicotinic receptor overstimulation that progresses to depolarizing neuromuscular blockade. 1
Dermal exposure route: The 2-hour delay between chemical spill on the arm and symptom onset is consistent with dermal organophosphate absorption, which manifests more gradually than inhalation exposure and typically begins with localized muscle twitching before progressing to respiratory compromise. 1
Treatment Protocol Confirms Organophosphate
Atropine administration is the cornerstone therapy for organophosphate poisoning, antagonizing life-threatening muscarinic effects (bronchospasm, bronchorrhea, bradycardia). 1
Pralidoxime (oxime) therapy is specifically indicated for organophosphate poisoning because it reactivates acetylcholinesterase before the enzyme-inhibitor complex undergoes irreversible "aging," thereby reversing nicotinic paralysis and restoring respiratory muscle strength. 1, 2
Parathion specifically requires metabolic activation to paraoxon by cytochrome P450 enzymes, making it a potent acetylcholinesterase inhibitor. 2
Why the Other Options Are Incorrect
Carbaryl (A) – Carbamate Insecticide
Carbaryl produces reversible acetylcholinesterase inhibition, unlike organophosphates. 3
While carbaryl can cause similar cholinergic symptoms, pralidoxime use for carbamate poisoning has insufficient evidence and is not routinely recommended, though it should not be withheld when the poison class is unknown. 1
The physician's decision to use pralidoxime after "confirming the identity of the solution" strongly suggests an organophosphate rather than a carbamate. 1
2,4-Dichlorophenoxyacetic Acid (B) – Herbicide
This phenoxy herbicide does not cause cholinergic toxicity or acetylcholinesterase inhibition. 4
Toxicity manifests as oxidative stress, mitochondrial dysfunction, and cellular apoptosis—not the muscarinic/nicotinic syndrome seen here. 4
Neither atropine nor pralidoxime would be indicated for 2,4-D exposure. 4
Paraquat (C) – Herbicide
Paraquat causes severe pulmonary toxicity through oxidative damage and multi-organ failure, not cholinergic crisis. 5, 6
Clinical presentation includes gastrointestinal injury, acute kidney injury, and progressive pulmonary fibrosis—not the salivation, wheezing, and bradycardia seen in this patient. 5
Treatment focuses on extracorporeal therapies (hemoperfusion, CRRT) to enhance clearance, not atropine or pralidoxime. 5
Pyrethrin (E) – Botanical Insecticide
Pyrethrins are generally low in toxicity and do not inhibit acetylcholinesterase. 3
They act on sodium channels in insects and rarely cause significant human toxicity beyond mild dermatitis or allergic reactions.
Atropine and pralidoxime would not be appropriate treatments for pyrethrin exposure.
Critical Management Principles for Organophosphate Poisoning
Immediate Priorities
High-dose atropine must be initiated immediately and titrated aggressively—starting with 2 mg IV and doubling every 5 minutes until atropinization endpoints are achieved (clear lungs, heart rate >80 bpm, systolic BP >80 mmHg). 1
Early pralidoxime administration is essential before enzyme "aging" occurs (within minutes to hours), as delayed therapy becomes ineffective. 1, 2
Decontamination requires removal of all contaminated clothing and copious irrigation with soap and water to prevent ongoing dermal absorption. 1
Common Pitfalls to Avoid
Never underdose atropine—cumulative doses of 10–20 mg in the first 2–3 hours and >50 mg daily are routine and life-saving; failure to reach atropinization is a leading cause of preventable death. 1
Never mistake nicotinic signs for atropine toxicity—muscle weakness, fasciculations, and paralysis are caused by the organophosphate itself and require pralidoxime plus mechanical ventilation, not cessation of atropine. 1
Never delay intubation—early airway protection is associated with improved survival, but avoid succinylcholine and mivacurium because they are metabolized by cholinesterase. 1